Actavis Pharma, Inc. Recalls

2 recalls found for Actavis Pharma, Inc.. Check if any of your products are affected.

Health & Personal Care
HIGH
FDA DRUG

Teva Metoprolol Succinate 50 mg Extended-Release Recall 2026 Following Failed Dissolution Specs (67,

Teva Pharmaceuticals recalled 67,043 bottles of Metoprolol Succinate Extended-Release Tablets, 50 mg, distributed nationwide. The FDA enforcement report cites Failed Dissolution Specifications as the hazard. Health care providers and patients should stop using this product immediately and contact Teva for guidance.

METOPROLOL SUCCINATE
Failed Dissolution
Read more
Health & Personal Care
HIGH
FDA DRUG

Actavis Recalls Testosterone Gel Due to Leakage Risk

Actavis Laboratories recalled 15,944 cartons of Testosterone Gel on November 7, 2025. The recall follows a defect in the side-seal of the containers, which may allow product leakage. Consumers must stop using the product immediately and contact their healthcare providers for guidance.

TESTOSTERONE
Defective Container
Read more

Brand Statistics

Total Recalls
2
Pages
1

Related Brands

METOPROLOL SUCCINATETESTOSTERONE